Clinical Trial Update: Phase II Study of Intravenous Rexin-G in Osteosarcoma [Phase 2]

View source ↗

Summary

Phase II study of intravenous Rexin-G in osteosarcoma has completed. The update provides no detailed results in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Rexin-G

Snippet

Sponsor: Epeius Biotechnologies | Conditions: Osteosarcoma | Phase 2 | Status: COMPLETED